BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$17.19 USD
+0.33 (1.96%)
Updated Apr 26, 2024 10:12 AM ET
4-Sell of 5 4
F Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 16.67% |
ABR | 1.22 |
Earnings ESP
|
-49.02% |
---|---|
Current Year | -0.66 |
Next Year | -0.52 |
EPS (TTM) | -1.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 29.30M | 22.50M | 117.07M | 141.70M |
# of Estimates | 3 | 2 | 3 | 3 |
High Estimate | 33.70M | 23.00M | 146.80M | 173.10M |
Low Estimate | 21.50M | 22.00M | 97.50M | 112.00M |
Year ago Sales | 37.70M | 39.51M | 143.27M | 117.07M |
Year over Year Growth Est. | -22.28% | -43.05% | -18.29% | 21.04% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.16 | -0.66 | -0.52 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.13 | -0.11 | -0.35 | NA |
High Estimate | -0.13 | -0.11 | -0.35 | -0.48 |
Low Estimate | -0.38 | -0.20 | -0.85 | -0.55 |
Year ago EPS | -0.32 | -0.23 | -1.52 | -0.66 |
Year over Year Growth Est. | 18.75% | 30.43% | 56.58% | 21.47% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.16 | -0.66 | -0.52 |
7 Days Ago | -0.26 | -0.16 | -0.66 | -0.52 |
30 Days Ago | -0.13 | -0.11 | -0.67 | NA |
60 Days Ago | NA | NA | -0.60 | NA |
90 Days Ago | NA | NA | -0.62 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.20 | -0.81 | -0.52 |
Zacks Consensus Estimate | -0.26 | -0.16 | -0.66 | -0.52 |
Earnings ESP | -49.02% | -29.03% | -23.35% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.67 | -0.23 | -0.32 | NA |
Estimate | -0.36 | -0.38 | -0.18 | -0.20 | NA |
Difference | 0.06 | -0.29 | -0.05 | -0.12 | -0.10 |
Surprise | 16.67% | -76.32% | -27.78% | -60.00% | -36.86% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more